Predictive Oncology Inc
NASDAQ:POAI
Relative Value
The Relative Value of one
POAI
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 5.48 USD,
Predictive Oncology Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
POAI Competitors Multiples
Predictive Oncology Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Predictive Oncology Inc
NASDAQ:POAI
|
18.6m USD | 25.5 | -0.2 | -1.8 | -1.8 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
60B USD | 0 | 0 | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
8.9T JPY | 9.8 | 35.7 | 25.7 | 30.9 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.6B CHF | 3.8 | 37.3 | 15.4 | 30 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
109.6B DKK | 3.9 | 27.5 | 14.3 | 17.1 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.5B USD | 3.4 | 35.5 | 16.1 | 20.5 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 2.7 | 29.2 | 13 | 21.1 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.8B CNY | 9.4 | 26 | 23.5 | 23.5 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6B USD | 1.2 | -19.7 | 19.6 | 92.4 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
3.9B CHF | 5 | 20.4 | 13.2 | 18 | |
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
4.8B USD | 3.2 | 40.4 | 18.4 | 30.7 |